BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15814586)

  • 1. Common chromosomal fragile site FRA16D mutation in cancer cells.
    Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
    Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal fragile site FRA16D and DNA instability in cancer.
    Mangelsdorf M; Ried K; Woollatt E; Dayan S; Eyre H; Finnis M; Hobson L; Nancarrow J; Venter D; Baker E; Richards RI
    Cancer Res; 2000 Mar; 60(6):1683-9. PubMed ID: 10749140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal fragile sites FRA3B and FRA16D show correlated expression and association with failure of apoptosis in lymphocytes from patients with thyroid cancer.
    Sbrana I; Veroni F; Nieri M; Puliti A; Barale R
    Genes Chromosomes Cancer; 2006 May; 45(5):429-36. PubMed ID: 16419058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common fragile sites and cancer (review).
    Smith DI; Huang H; Wang L
    Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
    Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
    Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
    Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
    Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.
    Ried K; Finnis M; Hobson L; Mangelsdorf M; Dayan S; Nancarrow JK; Woollatt E; Kremmidiotis G; Gardner A; Venter D; Baker E; Richards RI
    Hum Mol Genet; 2000 Jul; 9(11):1651-63. PubMed ID: 10861292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L; Darling J; Zhang JS; Qian CP; Hartmann L; Conover C; Jenkins R; Smith DI
    Oncogene; 1998 Feb; 16(5):635-42. PubMed ID: 9482109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
    Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
    Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRA16D common chromosomal fragile site oxido-reductase (FOR/WWOX) protects against the effects of ionizing radiation in Drosophila.
    O'Keefe LV; Liu Y; Perkins A; Dayan S; Saint R; Richards RI
    Oncogene; 2005 Sep; 24(43):6590-6. PubMed ID: 16007179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae.
    Zhang H; Freudenreich CH
    Mol Cell; 2007 Aug; 27(3):367-79. PubMed ID: 17679088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common fragile genes.
    Matsuyama A; Croce CM; Huebner K
    Eur J Histochem; 2004; 48(1):29-36. PubMed ID: 15145773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of late/slow replication of the FRA16D in common fragile site induction.
    Palakodeti A; Han Y; Jiang Y; Le Beau MM
    Genes Chromosomes Cancer; 2004 Jan; 39(1):71-6. PubMed ID: 14603443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
    Shridhar V; Wang L; Rosati R; Paradee W; Shridhar R; Mullins C; Sakr W; Grignon D; Miller OJ; Sun QC; Petros J; Smith DI
    Oncogene; 1997 Mar; 14(11):1269-77. PubMed ID: 9178887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.